AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
CORPORATE: Emerging markets growth helps Ranbaxy return to black.
from BUSINESS LINE, October 27, 2009 New Delhi, Oct. 26 - Riding on its growth in the emerging markets, Ranbaxy Laboratories Ltd on Monday reported consolidated profits of Rs 116.6 crore for the third quarter ended September 30 compared with a loss of Rs 394.5 crore in the same period last year.
However, a huge dip in US sales pulled down its income by 18 per cent to Rs 1,720.5 crore compared with Rs 1,888.4 crore in the corresponding quarter last year.
On a standalone basis, Ranbaxy reported to the BSE a net profit of Rs 186 crore compared with a loss of Rs 352 crore last year. Standalone income stood at Rs 439 crore in Q3 2009.
Commenting on the results …
-
- Nickel: Demand from emerging markets to push prices north. [1 figure in...
-
Magazine article from: India Business Insight
August 4, 2010
700+ words
-
- Biocon rides on emerging markets. (Biocon has regained its number one slot...
-
Magazine article from: India Business Insight
June 4, 2010
700+ words
-
- Mobius still bets on emerging markets.
-
News wire article from: Business Line
March 29, 2011
700+ words
-
- Emerging Markets acquires 5.6 pc stake in Birla Corp.
-
News wire article from: Asia Africa Intelligence Wire
July 16, 2004
700+ words
-
- Local indices echo crash in emerging markets.
-
News wire article from: Asia Africa Intelligence Wire
October 26, 2005
700+ words
